BioSpace News Archive

An individual participant in Nordic Nanovector ASA’s previous share option program, not being a primary insider, has exercised a total number of 17,392 options through exercise of a corresponding number of free-standing warrants. 14,374 of the options are exercised at a strike price of NOK 30.00 per share, and 3,018 of the options are exercised at a strike price of NOK 14.24.

KEYTRUDA® (pembrolizumab) in Combination with Pemetrexed and Platinum Chemotherapy Reduced the Risk of Death by Half Compared to Chemotherapy Alone

Harvest One Cannabis Inc., through it’s wholly-owned subsidiary United Greeneries Ltd. announced that it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart.

Dr. Darlyne Bailey has been named Chair of the Board of Directors of Ultimate Medical Academy, a Tampa-based nonprofit higher education institution, effective immediately.

Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, reported financial results for the fourth quarter and year ended December 31, 2018 and provided a corporate update.

Ms. Casner will serve on the Executive Leadership Team and report to George Fotiades, President and CEO.

Unique, person-centered information mined by solution with predictive algorithms sheds light into risk factors for depression and other health conditions

Biocept expands intellectual property position to 32 issued patents globally for its highly sensitive methods for detecting cancer biomarkers in blood and other specimen types

Boston Heart Diagnostics announced the publication of a new research study: “Cardiovascular Risk Factor Reduction in First Responders Resulting from and Individualized Lifestyle and Blood Test Program: A Randomized Controlled Trial”.

Ono Pharmaceutical Co., Ltd. announced that the companies have signed a drug discovery research collaboration to jointly discover and develop novel, efficacious treatments to address unmet medical needs in a specific neurological disease.